文献速递间质性肺疾病

特发性肺纤维化高分辨率CT纤维化评分:性能特征

Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis.
PubMed 文献 · Eur Respir J · 2018-09-17

该研究基于两项介入临床试验中141例特发性肺纤维化(IPF)患者,评估数据驱动纹理分析(DTA)这一HRCT肺纤维化定量指标的可靠性、有效性、反应性,并估计其最小临床重要差异(MCID)。结果显示DTA具有可接受的可靠性、有效性和反应性,以FVC为锚定变量估计MCID为3.4%。

要点

  • DTA在HRCT上定量肺纤维化程度具有可接受的可靠性、有效性和反应性。
  • 以FVC为锚定变量,DTA评分变化的MCID估计为3.4%。
  • DTA评分与FVC等临床指标的相关性为中至弱,方向符合预期。

核心结论

  • DTA在HRCT上定量肺纤维化程度可靠、有效且具有反应性。
  • DTA评分增加约3.4%代表具有临床意义的变化。

研究设计与样本

  • 研究纳入来自两项介入临床试验的141例IPF患者,均有基线和名义54周或60周随访HRCT。
  • 计算DTA评分并与FVC、DLCO、6分钟步行距离和圣乔治呼吸问卷评分比较,评估可靠性、有效性和反应性。
  • 采用锚定法和分布法估计MCID。

主要发现

  • 在随访时根据锚定变量判断为稳定的受试者中,DTA具有可接受的可靠性。
  • 基线时DTA评分与其他临床测量之间的相关性为中至弱,方向符合假设。
  • DTA评分变化与其他参数变化之间的相关性为中至弱(方向符合假设),显示可接受的反应性。
  • 以FVC为锚定变量,MCID估计为3.4%。

关键数值与推荐

  • 以FVC为锚定变量,DTA评分的MCID估计为3.4%。

临床怎么用

  • DTA可作为HRCT上定量IPF肺纤维化程度的可靠、有效且反应性良好的指标。
  • DTA评分增加约3.4%可视为具有临床意义的变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We evaluated performance characteristics and estimated the minimal clinically important difference (MCID) of data-driven texture analysis (DTA), a high-resolution computed tomography (HRCT)-derived measurement of lung fibrosis, in subjects with idiopathic pulmonary fibrosis (IPF).The study population included 141 subjects with IPF from two interventional clinical trials who had both baseline and nominal 54- or 60-week follow-up HRCT. DTA scores were computed and compared with forced vital capacity (FVC), diffusing capacity of the lung for carbon monoxide, distance covered during a 6-min walk test and St George's Respiratory Questionnaire scores to assess the method's reliability, validity and responsiveness. Anchor- and distribution-based methods were used to estimate its MCID.DTA had acceptable reliability in subjects appearing stable according to anchor variables at follow-up. Correlations between the DTA score and other clinical measurements at baseline were moderate to weak and in the hypothesised directions. Acceptable responsiveness was demonstrated by moderate to weak correlations (in the directions hypothesised) between changes in the DTA score and changes in other parameters. Using FVC as an anchor, MCID was estimated to be 3.4%.Quantification of lung fibrosis extent on HRCT using DTA is reliable, valid and responsive, and an increase of ∼3.4% represents a clinically important change.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Humphries SM, Swigris JJ, Brown KK, et al. Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis. Eur Respir J. 2018. PMID: 30139770. doi:10.1183/13993003.01384-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。